EGFR and neoplasm: developed an epidermal growth factor receptor (EGFR)‐targeted hyperpH‐sensitive nano‐PS and systematically evaluated its active targeting ability and therapeutic efficacy after modulation of the tumor vasculature system and stromal barrier (Figure 7B).